0 NASDAQ Companies - September 3, 2020Ocugen to Present at the H.C. Wainwright 22nd Annual Global Investment ConferenceMALVERN, Pa., Sept. 03, 2020 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and […]Read More
0 NASDAQ Companies - September 3, 2020Primoris Services Corporation Announces Pipeline Awards Valued Over $75 MillionDALLAS, Sept. 03, 2020 (GLOBE NEWSWIRE) — Primoris Services Corporation (NASDAQ Global Select: PRIM) (“Primoris” or “Company”) today announced three […]Read More
0 NASDAQ Companies - September 3, 2020Crinetics Pharmaceuticals Appoints Rare Disease Executive, Camille L. Bedrosian, M.D., to Board of DirectorsSAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on […]Read More
0 NASDAQ Companies - September 3, 2020PAE to Present at the Deutsche Bank Technology ConferenceFALLS CHURCH, Va., Sept. 03, 2020 (GLOBE NEWSWIRE) — PAE (NASDAQ: PAE, PAEWW) will present at the Deutsche Bank Technology […]Read More
0 NASDAQ Companies - September 3, 2020Translate Bio to Participate in Upcoming Investor ConferencesLEXINGTON, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) — Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing […]Read More
0 TSX News - September 3, 2020Sabina Gold & Silver Continues to Intersect Exceptional High Grade from Drilling at Umwelt UndergroundResults include 19.89 g/t Au* over 32.20 m in drill hole 20GSE575C, including 51.50 g/t Au* over 8.20 m *weighted […]Read More
0 TSX News - September 3, 2020Live Webinar and Q&A Marimaca Project PEA Results: US$524 million post-tax real NPV8 and 33.5% IRRThe Preliminary Economic Assessment (“PEA”) was prepared in accordance with the requirements of the National Instrument 43-101,Standards of Disclosure for […]Read More
0 NASDAQ Companies - September 3, 2020RedHill Biopharma’s Opaganib Awarded COVID-19 Grant by State of PennsylvaniaA global Phase 2/3 study in up to 270 patients hospitalized with severe COVID-19 pneumonia, and a U.S. Phase 2 […]Read More
0 NASDAQ Companies - September 3, 2020Sol-Gel Technologies Collaboration Partner Filed First-to-File Paragraph IV Certification for Duobrii®Patent challenge initiated by Bausch Health CompaniesNESS ZIONA, Israel, Sept. 03, 2020 (GLOBE NEWSWIRE) — Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), […]Read More
0 TSX News - September 3, 2020MediPharm Labs Enters Growing Latin American Medical Cannabis Market; Enters Supply Agreement With Cann Farm PeruBARRIE, Ontario, Sept. 03, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or […]Read More